Clinical Trials Logo

Clinical Trial Summary

To compare the safety and tolerability of brimonidine tartrate ophthalmic solution 0.025% versus its vehicle in a population of pediatric, adult, and geriatric participants. At least 51% of participants will be 40 years of age or older.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01959243
Study type Interventional
Source Bausch & Lomb Incorporated
Contact
Status Completed
Phase Phase 3
Start date February 22, 2014
Completion date June 23, 2014

See also
  Status Clinical Trial Phase
Completed NCT02136589 - Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes Phase 4
Completed NCT01959230 - Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness Phase 3
Recruiting NCT05706181 - Heat Therapy, Functional Capacity, and Vascular Health in Older Adults Phase 1/Phase 2
Completed NCT01642147 - Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy N/A
Withdrawn NCT04132648 - Curcumin and Exercise in Chronic Kidney Disease Phase 2
Recruiting NCT02183779 - PORH and Response to Cold in Raynaud's Phenomenon. N/A
Completed NCT02039765 - Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. Phase 1
Completed NCT00268554 - Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole N/A